Christopher Parker - Dana-Farber Targeted Degradation Webinar Series

Christopher Parker - Scripps Research "Chemoproteomic-Enabled Development of Proximity-Modulating Molecules" #dfci About Dana-Farber Targeted Protein Degradation Webinar Series: Targeted protein degradation (TPD) is a rapidly growing interdisciplinary area of research of both basic science and translational importance. TPD is primarily concerned with the development of agents that induce degradation of protein targets. The precise removal of the target is often linked to a therapeutically beneficial phenotype, making TPD of high interest for drug discovery and development. This webinar series brings together the community of scientists interested in TPD and rapid dissemination of knowledge and best practices. To learn more and join the future webinars please visit: www.danafarbertargetedproteindegradation.org

Michelle Arkin - Dana-Farber Targeted Degradation Webinar Series
▶︎

Michelle Arkin - Dana-Farber Targeted Degradation Webinar Series

Covalent ligand discovery for chemical probes to challenging targets – 16 February 2021
▶︎

Covalent ligand discovery for chemical probes to challenging targets – 16 February 2021

Rocky Mountain Highlights 2023 I Session I: High Yield Topics in Luminal Gastroenterology
▶︎

Rocky Mountain Highlights 2023 I Session I: High Yield Topics in Luminal Gastroenterology

AlphaFold - The Most Useful Thing AI Has Ever Done
▶︎

AlphaFold - The Most Useful Thing AI Has Ever Done

Why AI Hasn't Cured Anything...Yet, According to Jennifer Doudna | The Circuit
▶︎

Why AI Hasn't Cured Anything...Yet, According to Jennifer Doudna | The Circuit

Craig Crews -  Dana-Farber Targeted Degradation Webinar Series
▶︎

Craig Crews - Dana-Farber Targeted Degradation Webinar Series

Confocal Microscopy
▶︎

Confocal Microscopy

An industry perspective on common practice in forced degradation studies of biopharma webinar
▶︎

An industry perspective on common practice in forced degradation studies of biopharma webinar

Nobel Prize lecture: Demis Hassabis, Nobel Prize in Chemistry 2024
▶︎

Nobel Prize lecture: Demis Hassabis, Nobel Prize in Chemistry 2024

SFPM Seminar - June 10, 2026
▶︎

SFPM Seminar - June 10, 2026

Exploring the structural basis for kinetic transitions with 5D-SSX
▶︎

Exploring the structural basis for kinetic transitions with 5D-SSX

“Curing All Disease by next century is too conservative" - Mark Zuckerberg
▶︎

“Curing All Disease by next century is too conservative" - Mark Zuckerberg

Stem Cells, Space, and Liver Metabolism - Medicine Informing Novel Discoveries (MIND)
▶︎

Stem Cells, Space, and Liver Metabolism - Medicine Informing Novel Discoveries (MIND)

Engineering Functionally Improved CAR T cells with a Multi-Cytokine Backpack Platform | REBEL System
▶︎

Engineering Functionally Improved CAR T cells with a Multi-Cytokine Backpack Platform | REBEL System

A New Hope in Type 1 Diabetes Research | 2024 | TCOYD Virtual Diabetes Conference
▶︎

A New Hope in Type 1 Diabetes Research | 2024 | TCOYD Virtual Diabetes Conference

Demystifying NIH K Awards: Insights from Funded Global Cancer Research Applications
▶︎

Demystifying NIH K Awards: Insights from Funded Global Cancer Research Applications

How AI Cracked the Protein Folding Code and Won a Nobel Prize
▶︎

How AI Cracked the Protein Folding Code and Won a Nobel Prize

Dan Nomura - Dana-Farber Targeted Degradation Webinar Series
▶︎

Dan Nomura - Dana-Farber Targeted Degradation Webinar Series

Scalable Tools to Map T Cell Recognition | Dr Stephanie Gaglione (Gladstone Institutes & MIT)
▶︎

Scalable Tools to Map T Cell Recognition | Dr Stephanie Gaglione (Gladstone Institutes & MIT)

Bioelectricity, Morphogenesis, and Two-Headed Worms | Michael Levin
▶︎

Bioelectricity, Morphogenesis, and Two-Headed Worms | Michael Levin